INTEGRATED BIOPHARMA INC Annual Net Income (Loss) Attributable to Parent in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Integrated Biopharma Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2024.
  • Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $259K.
  • Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $430K.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2024 was $112K.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$34K, a 101% decline from 2022.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2022 was $3.84M, a 52.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.